The Joint Corp. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2015

Dec. 31, 2014

Accounting Policies [Abstract]

Schedule of Franchisor Disclosure [Table Text Block]

		Three Months Ended June 30,								Six Months Ended June 30,
Franchised clinics:		2015				2014				2015				2014
Clinics open at beginning of period			241				192				242				175
Opened during the period			10				23				23				41
Acquired during the period			(11	)			-				(21	)			-
Closed during the period			(1	)			-				(5	)			(1	)
Clinics in operation at the end of the period			239				215				239				215

Franchises sold but not yet operational			230				250				230				250

		Three Months Ended June 30,								Six Months Ended June 30,
Corporate owned or managed clinics:		2015				2014				2015				2014
Clinics open at beginning of period			12				-				4				-
Acquired during the period			11				-				21				-
Closed during the period			-				-				(2	)			-
Clinics in operation at the end of the period			23				-				23				-

Total clinics in operation at the end of the period			262				215				262				215

		Year Ended December 31,
		2014				2013
Clinics open at beginning of period			175				82
Clinics opened during the period			73				93
Clinics closed during the period			(2	)			-
Clinics in operation at the end of the period			246				175

Clinics sold but not yet operational			268				223

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

		Three Months Ended June 30,								Six Months Ended June 30,
		2015				2014				2015				2014

Net income (loss)		$	(1,855,870	)		$	(133,749	)		$	(3,759,593	)		$	(261,646	)

Weighted average common shares outstanding - basic			9,768,230				4,819,902				9,734,115				4,815,754
Effect of dilutive securities:
Stock options			-				-				-				-
Weighted average common shares outstanding - diluted			9,768,230				4,819,902				9,734,115				4,815,754

Basic and diluted loss per share		$	(0.19	)		$	(0.03	)		$	(0.39	)		$	(0.05	)

		Year Ended December 31,
		2014				2013

Net income (loss)		$	(3,031,220	)		$	155,635

Weighted average common shares outstanding - basic			5,451,851				5,313,665
Effect of dilutive securities:
Stock options			-				21,732
Shares issuable on conversion of preferred stock			-				1,335,000
Weighted average common shares outstanding - diluted			5,451,851				6,670,397

Basic earnings per share		$	(0.56	)		$	0.03
Diluted earnings per share		$	(0.56	)		$	0.02

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

		Three Months Ended June 30,								Six Months Ended June 30,
		2015				2014				2015				2014
Unvested restricted stock			453,846				116,818				453,846				116,818
Stock options			376,275				271,895				376,275				271,895
Warrants			90,000				-				90,000				-

		Year Ended December 31,
		2014				2013
Unvested restricted stock			590,873				-
Stock options			312,995				-
Warrants			90,000				-